Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4.35p
   
  • Change Today:
    -0.25p
  • 52 Week High: 11.85p
  • 52 Week Low: 3.40p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 1,047,016
  • Market Cap: £23.20m

Deal with Barclays    Trade now with Barclays Stockbrokers

Eden Research shares rise on EU product approval

By Josh White

Date: Tuesday 07 Jan 2020

LONDON (ShareCast) - (Sharecast News) - Biopesticide and microencapsulation technology developer Eden Research announced on Tuesday that its three EU-registered active ingredients - geraniol, eugenol and thymol - had all been approved for use in organic farming, following their inclusion in the EU's Organic Production Regulation.
The AIM-traded firm said organic farming covered 12.6 million hectares of agricultural land in EU member states in 2017, equivalent to 7% of the total utilised agricultural area.

Between 2012 and 2017, land assigned for organic growing within those member states increased by 25%.

In Italy and Spain, the conversion rates from conventional to organic agriculture grew by over 60%, with the share of organic production there totalling 15.2% and 13.9%, respectively.

Under the approval, Eden said its products would provide organic growers with high levels of efficacy "often associated" with conventional chemical pesticides, thus providing the company's growers with another alternative and sustainable solution.

"We are very excited by this approval for EU organic farming as this opens up a new commercial opportunity for Eden which is relevant to all of the products that we have developed and continue to develop using our three EU registered active ingredients," said chief executive officer Sean Smith.

"It is clear that there is growing demand from consumers within the EU for organic products and this is matched by rapidly growing production.

"Consequently, areas assigned by EU Member States for organic agriculture have grown by 70% in the last 10 years, with organic retail sales reaching €34bn in 2017."

At 1427 GMT, shares in Eden Research were up 12.44% at 10.12p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Eden Research Market Data

Currency UK Pounds
Share Price 4.35p
Change Today -0.25p
% Change -5.43 %
52 Week High 11.85p
52 Week Low 3.40p
Volume 1,047,016
Shares Issued 533.35m
Market Cap £23.20m

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average28.67% below the market average
54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average54.39% above the sector average
Income Not Available
Growth
5.39% above the market average5.39% above the market average5.39% above the market average5.39% above the market average5.39% above the market average
8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average8.11% above the sector average

Eden Research Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
14:28 10,000 @ 4.46p
13:30 140,000 @ 4.47p
13:11 40,000 @ 4.21p
11:47 279,960 @ 4.21p
11:46 280,675 @ 4.20p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page